Hemo Organic Ltd Financials
Company Logo

Hemo Organic Ltd Financial Statement

Hemo Organic Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Jun 2025
RevenueTBA
Operating Expense0.12
Net Profit-0.09
Net Profit MarginTBA
Earning Per Share-0.25
EBIDTA-0.09
Effective Tax RateTBA

Hemo Organic Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Total Revenue Annual2.41
Operating Expenses Annual2.46
Operating Profit Annual0.03
Interest AnnualTBA
DepreciationTBA
Net Profit Annual0.16
Tax Annual-0.14

Hemo Organic Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Cash Flow at the Beginning0.13
Cash Flow from Operations-0.36
Cash Flow from InvestingTBA
Cash Flow from Financing0.24
Cash Flow at the End0.01

Hemo Organic Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
PBDIT Margin (%)1.24
PBIT Margin (%)1.24
PBT Margin (%)1.24
Net PROFIT Margin (%)6.64
Return On Networth / Equity (%)10.13
Return On Networth /Employed (%)0.68
Return On Assets (%)14.21
Total Debt / Equity (X)TBA
Asset Turnover Ratio (%)2.14

Hemo Organic Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Fixed Assets Annual0.00
Total Current Assets Annual4.69
Non Current Assets Annual0.28
Total Shareholders Funds Annual-0.15
Total Assets Annual4.98

Hemo Organic Ltd Earning Calls

No Data Availabe

FAQS on Hemo Organic Ltd Financials

As of Sep 15, 2025, Hemo Organic Ltd has a market capitalization of 3.11 Cr. Value Research classifies it as a Micro-Cap company.

Yes, Hemo Organic Ltd is with a debt-to-equity ratio of -9.77.

In FY 2024 , Hemo Organic Ltd recorded a total revenue of approximately 2.41 Cr marking a significant milestone in the company's financial performance.

Hemo Organic Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.1% and Infinity% annually, respectively..

Hemo Organic Ltd's current PE ratio is 19.44.

Hemo Organic Ltd's ROCE averaged 105.5% from the FY ending March 2023 to 2025, with a median of 1.9%. It peaked at 341.3% in March 2023, reflecting strong capital efficiency over the period..

Hemo Organic Ltd's latest EBIT is Rs. 0.03 Cr, surpassing the average EBIT of Rs. -0.09 Cr over the 5 years..

Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions